StockData
Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc. (ATRA) stock

ATRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/30
$6.50+0.10 (+1.56%)

Close on Nov 17, 2026Market cap $65.25MP/E –Yield –

Atara Biotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Atara Biotherapeutics's market cap was $77.72M on Nov 11, 2026, against $108.87M a year earlier. Over the last 5 years it ranged from $34.64M to $1.39B, with a median of $84.08M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$77.72M-40.4%
2025Dec 31, 2025$130.43M+70.7%
2024Dec 31, 2024$76.40M+46.2%
2023Dec 29, 2023$52.27M-83.2%
2022Dec 30, 2022$311.20M-77.7%
2021Dec 31, 2021$1.39B-8.1%
2020Dec 31, 2020$1.52B+70.0%
2019Dec 31, 2019$891.44M-43.8%
2018Dec 31, 2018$1.59B+286201.1%
2017Dec 29, 2017$553.86K-99.9%
2016Dec 30, 2016$409.56M-45.3%
2015Dec 31, 2015$748.09M+1752.4%
2014Dec 31, 2014$40.38M–

More Atara Biotherapeutics figures

See a number that looks wrong?